$577 Million is the total value of Parkman Healthcare Partners LLC's 95 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 44.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COO | Sell | COOPER COS INC | $15,384,362 | -21.3% | 40,123 | -23.4% | 2.67% | -37.3% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $13,177,011 | -40.2% | 139,735 | -35.9% | 2.28% | -52.4% |
| HAE | Sell | HAEMONETICS CORP MASS | $9,796,294 | -15.9% | 115,061 | -18.2% | 1.70% | -33.0% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $8,476,865 | -13.5% | 400,987 | -17.8% | 1.47% | -31.1% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $8,382,990 | -15.5% | 217,740 | -21.5% | 1.45% | -32.7% |
| TGTX | Sell | TG THERAPEUTICS INC | $5,480,549 | +32.2% | 220,634 | -20.0% | 0.95% | +5.3% |
| HUM | Sell | HUMANA INC | $4,989,971 | -42.4% | 11,160 | -37.4% | 0.86% | -54.1% |
| SGEN | Sell | SEAGEN INC | $4,349,981 | -70.6% | 22,602 | -69.1% | 0.75% | -76.6% |
| PFMT | Sell | PERFORMANT FINL CORP | $3,905,321 | -26.1% | 1,446,415 | -6.9% | 0.68% | -41.1% |
| NTRA | Sell | NATERA INC | $3,651,398 | -47.4% | 75,039 | -40.0% | 0.63% | -58.1% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $3,620,608 | -40.3% | 119,492 | -36.1% | 0.63% | -52.4% |
| SWAV | Sell | SHOCKWAVE MED INC | $2,875,791 | -71.7% | 10,076 | -78.5% | 0.50% | -77.4% |
| CDMO | Sell | AVID BIOSERVICES INC | $2,485,263 | -70.8% | 177,900 | -60.8% | 0.43% | -76.7% |
| LQDA | Sell | LIQUIDIA CORPORATION | $2,206,902 | -2.3% | 281,134 | -14.0% | 0.38% | -22.0% |
| Sell | MARINUS PHARMACEUTICALS INC | $1,857,875 | +7.7% | 171,075 | -31.6% | 0.32% | -14.1% | |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $153,692 | -79.8% | 136,011 | -77.3% | 0.03% | -83.7% |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -151,921 | -100.0% | -0.09% | – |
| Exit | AADI BIOSCIENCE INC | $0 | – | -75,961 | -100.0% | -0.12% | – | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.36% | – |
| Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -67,252 | -100.0% | -0.42% | – | |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -47,608 | -100.0% | -0.50% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -97,082 | -100.0% | -0.51% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -17,920 | -100.0% | -1.08% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -25,840 | -100.0% | -1.36% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -1,753,630 | -100.0% | -1.60% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -65,000 | -100.0% | -1.83% | – |
| IQV | Exit | IQVIA HLDGS INC | $0 | – | -45,643 | -100.0% | -1.97% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -27,671 | -100.0% | -2.07% | – |
| ANTM | Exit | ELEVANCE HEALTH INC | $0 | – | -21,643 | -100.0% | -2.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.